Prevalence of anxiety, depression, and post-traumatic stress disorder during the COVID-19 lockdown in patients with rheumatoid arthritis or systemic lupus erythematosus: a systematic review
- PMID: 40420061
- PMCID: PMC12107875
- DOI: 10.1186/s12888-025-06996-w
Prevalence of anxiety, depression, and post-traumatic stress disorder during the COVID-19 lockdown in patients with rheumatoid arthritis or systemic lupus erythematosus: a systematic review
Abstract
The COVID-19 pandemic and its associated lockdown measures had a profound impact on mental health, particularly among individuals with chronic illnesses. Patients with autoimmune arthritis, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), are already at increased risk for psychological disorders due to the chronic nature of their disease, physical disability, and long-term medication use. The added stress of the pandemic, including fear of infection, limited access to healthcare, and social isolation, may have further exacerbated mental health issues in this population. This systematic review aims to evaluate the prevalence of anxiety, depression, and post-traumatic stress disorder (PTSD) among individuals with autoimmune arthritis during the pandemic. A comprehensive search of major medical databases identified 18 relevant studies, encompassing 9,666 participants from various geographic regions. By synthesizing findings across diverse populations, this review examines the extent of the mental health burden in this vulnerable group and highlights the importance of mental health support during public health crises. Understanding these impacts can help guide future research and inform healthcare policies to better support autoimmune arthritis patients in times of crisis.
Keywords: Autoimmune arthritis; COVID-19; Depression; Lockdown; PTSD.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown.Rheumatol Int. 2021 Oct;41(10):1763-1772. doi: 10.1007/s00296-021-04952-x. Epub 2021 Jul 23. Rheumatol Int. 2021. PMID: 34297180 Free PMC article.
-
Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.Clin Rheumatol. 2023 Oct;42(10):2677-2690. doi: 10.1007/s10067-022-06486-4. Epub 2023 Jan 11. Clin Rheumatol. 2023. PMID: 36627529 Free PMC article. Review.
-
Post-COVID-19 depression and anxiety in patients with systemic lupus erythematosus.Lupus. 2023 Jul;32(8):974-982. doi: 10.1177/09612033231181663. Epub 2023 Jun 7. Lupus. 2023. PMID: 37283176 Free PMC article.
-
Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis.PLoS One. 2021 Mar 10;16(3):e0246454. doi: 10.1371/journal.pone.0246454. eCollection 2021. PLoS One. 2021. PMID: 33690641 Free PMC article.
-
Deployment of personnel to military operations: impact on mental health and social functioning.Campbell Syst Rev. 2018 Jun 1;14(1):1-127. doi: 10.4073/csr.2018.6. eCollection 2018. Campbell Syst Rev. 2018. PMID: 37131363 Free PMC article.
Cited by
-
Impact of Biologic Drugs on Comorbidity Outcomes in Rheumatoid Arthritis: A Systematic Review.J Clin Med. 2025 Jun 26;14(13):4547. doi: 10.3390/jcm14134547. J Clin Med. 2025. PMID: 40648921 Free PMC article. Review.
References
-
- WHO Timeline. - COVID-19.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
